Ellison says the settlement requires Novo Nordisk to provide insulin products—including Novolog, Tresiba ... at $35 per monthly prescription (3 vials or 2 packs of pens) for customers paying ...

Novo Nordisk's Novolog and Eli Lilly's Humalog – by 2024. The company said its products will cost no more than $30 per vial or $55 for five pen cartridges, adding that compares to around $329 ...

Merilog will be provided by prefilled pen in a 3 mL dose or in a multiple-dose 10 mL vial. It is for adults ... a planned 75% reduction in the cost of NovoLog. Then a few days later, Sanofi ...

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog ... wholesale prices of the originator insulin are around $329 per vial and ...

But what makes the rise in insulin prices different ... Novo Nordisks's Novolog first hit the market in August 2001 at $39.75, and as of July 2016, a vial comes with a list price of $255.40 ...

Insulin-aspart-szjj is the first rapid-acting insulin biosimilar approved and the third insulin product approved by the FDA.

Increasing access to safe, effective and high-quality medications at potentially lower cost remains a continued ... pen and a 10 mL multiple-dose vial. Like Novolog, Merilog should be given ...